Systematic Review of the Use of the WHO-5 Well-Being Index Across Different Disease Areas.

IF 3.4 3区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Advances in Therapy Pub Date : 2025-06-12 DOI:10.1007/s12325-025-03266-9

Arnau Domenech, Ismail Kasujee, Volker Koscielny, Christopher E M Griffiths

{"title":"Systematic Review of the Use of the WHO-5 Well-Being Index Across Different Disease Areas.","authors":"Arnau Domenech, Ismail Kasujee, Volker Koscielny, Christopher E M Griffiths","doi":"10.1007/s12325-025-03266-9","DOIUrl":null,"url":null,"abstract":"Background: Since its first publication in 1998, the 5-item World Health Organization Well-being index, WHO-5, has become one of the most widely used questionnaires to assess subjective psychological well-being.Aims: To perform a systematic review of the WHO-5 questionnaire, with a focus on its use across various disease areas and patient populations.Methods: Studies reporting the use of the WHO-5 were searched on the PubMed and PsycINFO databases (search December 2024). The classification of the different diseases or disorders was used following the 11th version of the International Classification of Diseases.Results: A total of 552 studies met the predefined criteria for inclusion in the review. We provide an overview of the WHO-5 use in all different disease areas, the psychological burden of the patients, and if available, the impact of the treatments on their well-being. The groups with the most publications refer to the Coronavirus disease (COVID)-19 pandemic (n = 161, 29.2%) followed by the group of mental, behavioral, or neurodevelopmental disorders (n = 141, 25.6%), and the group of endocrine, nutritional, and metabolic diseases (n = 120, 21.7%).Conclusions: The WHO-5 is a short questionnaire consisting of 5 positively formulated questions, which successfully detect when a disease impacts a person's subjective well-being. The scale proved to detect changes in well-being across various diseases around the world, and it should be considered in clinical practice and research.","PeriodicalId":7482,"journal":{"name":"Advances in Therapy","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12325-025-03266-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Since its first publication in 1998, the 5-item World Health Organization Well-being index, WHO-5, has become one of the most widely used questionnaires to assess subjective psychological well-being.

Aims: To perform a systematic review of the WHO-5 questionnaire, with a focus on its use across various disease areas and patient populations.

Methods: Studies reporting the use of the WHO-5 were searched on the PubMed and PsycINFO databases (search December 2024). The classification of the different diseases or disorders was used following the 11th version of the International Classification of Diseases.

Results: A total of 552 studies met the predefined criteria for inclusion in the review. We provide an overview of the WHO-5 use in all different disease areas, the psychological burden of the patients, and if available, the impact of the treatments on their well-being. The groups with the most publications refer to the Coronavirus disease (COVID)-19 pandemic (n = 161, 29.2%) followed by the group of mental, behavioral, or neurodevelopmental disorders (n = 141, 25.6%), and the group of endocrine, nutritional, and metabolic diseases (n = 120, 21.7%).

Conclusions: The WHO-5 is a short questionnaire consisting of 5 positively formulated questions, which successfully detect when a disease impacts a person's subjective well-being. The scale proved to detect changes in well-being across various diseases around the world, and it should be considered in clinical practice and research.

查看原文本刊更多论文

在不同疾病领域使用世卫组织5幸福指数的系统审查。

背景：自1998年首次出版以来，世界卫生组织幸福指数（WHO-5）已成为最广泛使用的评估主观心理健康的问卷之一。目的：对世卫组织-5调查问卷进行系统审查，重点关注其在不同疾病领域和患者群体中的使用情况。方法：在PubMed和PsycINFO数据库中检索报告使用WHO-5的研究（检索时间为2024年12月）。不同疾病或失调的分类是按照《国际疾病分类》第11版进行的。结果：共有552项研究符合纳入本综述的预定标准。我们概述了世卫组织5号标准在所有不同疾病领域的使用情况、患者的心理负担，以及治疗对其福祉的影响（如果有的话）。发表论文最多的是冠状病毒病（COVID -19）大流行（n = 161, 29.2%），其次是精神、行为或神经发育障碍（n = 141, 25.6%）和内分泌、营养和代谢疾病（n = 120, 21.7%）。结论：WHO-5是一份简短的问卷，由5个积极制定的问题组成，它成功地检测出疾病何时影响一个人的主观幸福感。该量表被证明可以检测世界各地各种疾病的幸福感变化，应该在临床实践和研究中加以考虑。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Therapy 医学-药学

CiteScore

7.20

自引率

2.60%

发文量

353

审稿时长

6-12 weeks

期刊介绍： Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.